Page 76 - GPD-2-1
P. 76

Gene & Protein in Disease                                  m1A-mediated ESCCAL-1 promotes ESCA stemness




            A                            B                                 E















            C                            D                                 F















            Figure 1. Expression of ESCCAL-1 in ESCA and its relationship with clinical parameters of patients. (A) UALCAN database was used to investigate the
            transcription levels of ESCCAL-1 in 11 esophageal epithelial samples, 80 EAC samples, and 81 ESCC samples. **P < 0.01, ****P < 0.0001. (B) UALCAN
            was employed to analyze the relationship between ESCCAL-1 expression and patients’ race with ESCA. **P < 0.01, ****P < 0.0001. (C and D) UALCAN
            was applied to observe the relationship between ESCCAL-1 expression and gender (C) or tumor stage (D) in ESCA. *P < 0.05, **P < 0.01, ***P < 0.001,
            ****P < 0.0001. (E and F) Kaplan-Meier Plotter database was utilized to analyze the relationship between the expression of ESCCAL-1 and the survival of
            EAC (E) or ESCC (F) patients.
            ESCCAL-1: Esophageal squamous cell carcinoma associated long non-coding RNA 1; ESCA: Esophageal cancer; EAC: Esophageal adenocarcinoma.

            that the expression of ESCCAL-1 in the three ESCA cell   3.3. ESCCAL-1 regulates stemness-related markers
            lines (TE1, KYSE70, EC1) was significantly higher than   expression
            that of the normal esophageal epithelial cell line Het-1A   Considering that ESCCAL-1 plays a key role in ESCA
            (Figure 2A). We then used recombinant lentiviral vectors   stemness, we wondered whether ESCCAL-1 might
            to knockdown (sh-AL1#1, sh-AL1#2;  Figure  2B) and   regulate the expression of stemness-related genes. We used
            overexpress (OE-AL1;  Figure  2C) ESCCAL-1 in ESCA   qRT-PCR to detect the changes in mRNA levels of a set
            cells to perform loss-of-function and gain-of-function   of markers associated with stemness  (including SOX2,
                                                                                             [17]
            experiments. Subsequently, both tumor sphere formation   CD44, ALDH1A1, Nanog, ZEB1, KLF4, Myc) in ESCA
            and  colony  formation  assays  were  used  to  evaluate  the   cells after ESCCAL-1 overexpression or knockdown. We
            stemness  of  ESCA  cells.  Results  from  tumor  sphere   found that overexpression of ESCCAL-1 led to significant
            formation experiments showed that the knockdown of   upregulation of the transcription levels of these stemness-
            ESCCAL-1 reduced the sphere-forming ability of TE1 cells   related genes (Figure  3A), among which CD44 and
            by about 60% (Figure  2D  and  E). In comparison, the   ALDH1A1 showed the greatest changes. In contrast, the
            overexpression of ESCCAL-1 promoted the sphere-forming   knockdown  of  ESCCAL-1  resulted  in  decreased  mRNA
            capacity of KYSE70 cells by about 40% (Figure 2D and F).   levels  of  some  stemness  markers  (Figure  3B).  We then
            Moreover, colony formation experiments confirmed that   cross-compared the results of  Figure  3A  and  B, and
            silencing ESCCAL-1 significantly limited the cloning   found that two stemness markers, CD44 and KLF4, were
            ability  of  TE1  cells  in  vitro  by  more  than  60%,  while   uniformly positively regulated by ESCCAL-1 (Figure 3C).
            upregulation of ESCCAL-1 enhanced the colony formation   Subsequent Western blot analysis further confirmed that
            of KYSE70  cells by more than two folds (Figure  2G–I).   upregulation of ESCCAL-1 increased the protein levels
            These data indicate that ESCCAL-1 participates in   of CD44 and KLF4 in ESCA cells, while downregulation
            maintaining ESCA stemness.                         of ESCCAL-1 decreased the levels of both proteins


            Volume 2 Issue 1 (2023)                         4                         https://doi.org/10.36922/gpd.305
   71   72   73   74   75   76   77   78   79   80   81